Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Martha A. C. Edelstein"'
Publikováno v:
International Journal of Systematic and Evolutionary Microbiology. 62:1766-1771
Legionella -like bacteria were isolated from the respiratory tract of two patients in California, USA, and South Australia, but were not thought to cause disease. These bacteria, strains F2632 and IMVS-3376T, were found to have identical Legionella m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91754658582c4c0707cfe788af1120b5
https://doi.org/10.1099/ijs.0.035709-0
https://doi.org/10.1099/ijs.0.035709-0
Publikováno v:
Antimicrobial Agents and Chemotherapy. 47:533-540
The activities of tigecycline (Wyeth Research) against extracellular and intracellular Legionella pneumophila and for the treatment of guinea pigs with L. pneumophila pneumonia were studied. The tigecycline MIC at which 50% of strains are inhibited f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64e1491243e784755372356f602aad03
https://doi.org/10.1128/aac.47.2.533-540.2003
https://doi.org/10.1128/aac.47.2.533-540.2003
Publikováno v:
Journal of Antimicrobial Chemotherapy. 48:667-675
The activity of BMS-284756 was studied against extracellular Legionella spp. and intracellular Legionella pneumophila, and for the treatment of guinea pigs with L. pneumophila pneumonia. The BMS-284756 MIC(50) of 22 different Legionella spp. strains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df8eeca44f450a57f2ff5fd0077d7b03
https://doi.org/10.1093/jac/48.5.667
https://doi.org/10.1093/jac/48.5.667
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:2204-2209
The activity of gemifloxacin against intracellular Legionella pneumophila and for the treatment of guinea pigs with L. pneumophila pneumonia was studied. Gemifloxacin, azithromycin, and levofloxacin (1 μg/ml) reduced bacterial counts of two L. pneum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f72e8fb8c525db40945c2a8f8295b67
https://doi.org/10.1128/aac.45.8.2204-2209.2001
https://doi.org/10.1128/aac.45.8.2204-2209.2001
Publikováno v:
Antimicrobial Agents and Chemotherapy. 49:2533-2535
LBM415 activity against extracellular and intracellular Legionella pneumophila was studied. The LBM415 MIC 50 for 20 Legionella sp. strains was 4 μg/ml, versus 0.06, 0.25, and ≤ 0.03 μg/ml for azithromycin, erythromycin, and levofloxacin, respect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bfadb98786e9f9b76e354ce24511e03
https://doi.org/10.1128/aac.49.6.2533-2535.2005
https://doi.org/10.1128/aac.49.6.2533-2535.2005
Autor:
Paul H. Edelstein, David Zhuang, Alejandra Rizo Patron, Suzanne F. O'Handley, Joshua G. Thomson, Andrew J. Baltus, Martha A. C. Edelstein, Michael Madaio
Publikováno v:
The FASEB Journal. 27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::446c504d5b50f708fd1e7c942dcd9f03
https://doi.org/10.1096/fasebj.27.1_supplement.806.5
https://doi.org/10.1096/fasebj.27.1_supplement.806.5
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:200-204
The activities of ceftriaxone, piperacillin, tazobactam, clavulanic acid, and combinations of ceftriaxone or piperacillin with tazobactam against 22 clinical Legionella isolates were measured by broth microdilution and macrodilution methods and in ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c0f8d30563f445d5f7cbb830c7b2b6
https://doi.org/10.1128/aac.38.2.200
https://doi.org/10.1128/aac.38.2.200
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:217-222
Azithromycin pharmacokinetics in Legionella pneumophila-infected and uninfected guinea pigs were assessed by measuring the drug concentration in whole lungs or the drug content in bronchoalveolar lavage (BAL) fluid in separate experiments. Azithromyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ca247a3d060d86ac2ba46a877b6b52
https://doi.org/10.1128/aac.38.2.217
https://doi.org/10.1128/aac.38.2.217
A total of 1,991 group B streptococcus (GBS) isolates, collected in 2008 and 2009, were tested for non-penicillin susceptibility by broth microdilution, disk testing, and oxacillin screening agar. No GBS isolates were non-penicillin susceptible. Oxac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::056e1f7aab44b9447d26de20b76ae577
https://europepmc.org/articles/PMC2849539/
https://europepmc.org/articles/PMC2849539/
Publikováno v:
Antimicrobial Agents and Chemotherapy. 36:2387-2391
The activities of fleroxacin against 22 clinical Legionella isolates were determined by agar and broth microdilution susceptibility testing. The fleroxacin MIC required to inhibit 90% of strains tested on buffered charcoal yeast extract agar medium s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81656d039db5b5dcd12d3cc3a290f166
https://doi.org/10.1128/aac.36.11.2387
https://doi.org/10.1128/aac.36.11.2387